misoprostol and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

misoprostol has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 1 studies

Other Studies

1 other study(ies) available for misoprostol and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

Article	Year
Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1. Cell stem cell, 2017, 09-07, Volume: 21, Issue:3 Topics: Alprostadil; Animals; beta Catenin; Cell Line, Tumor; Cell Self Renewal; Drug Synergism; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Misoprostol; Neoplastic Stem Cells; Proto-Oncogene Proteins c-fos; Receptors, Prostaglandin E, EP4 Subtype; Transcription Factor AP-1; Transcription, Genetic; Xenograft Model Antitumor Assays	2017

Article

Year

Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1.

Cell stem cell, 2017, 09-07, Volume: 21, Issue:3

Topics: Alprostadil; Animals; beta Catenin; Cell Line, Tumor; Cell Self Renewal; Drug Synergism; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Misoprostol; Neoplastic Stem Cells; Proto-Oncogene Proteins c-fos; Receptors, Prostaglandin E, EP4 Subtype; Transcription Factor AP-1; Transcription, Genetic; Xenograft Model Antitumor Assays

2017